AAP
OMGA

Arax Advisory Partners’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Arax Advisory Partners’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-54
Closed -$66 – 2802
2024
Q3 		$66 Hold
54
– – ﹤0.01% 2582
2024
Q2 		$112 Buy
+54
New +$127 ﹤0.01% 2485

Other funds holding OMGA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Arax Advisory Partners's OMGA Position: Q4 2024 in Review

Arax Advisory Partners sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q4 2024, closing a stake of 54 shares — an estimated $66 sold.

Arax Advisory Partners first reported a position in OMGA in Q2 2024 and held it in 2 quarters. The position peaked at $112 in Q2 2024. 53 funds tracked by Wall St. Rank hold OMGA as of Q4 2024.

  • Arax Advisory Partners reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Arax Advisory Partners sold 54 Omega Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $66.
  • Arax Advisory Partners first reported a position in Omega Therapeutics, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
  • Arax Advisory Partners's Omega Therapeutics, Inc. Common Stock position peaked at $112 in Q2 2024.
  • 53 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q4 2024.

Based on Arax Advisory Partners's 13F filing for Q4 2024, filed 5 Feb 2025.